Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 24, Issue 9, Pages 2449-2455
Publisher
Oxford University Press (OUP)
Online
2013-05-30
DOI
10.1093/annonc/mdt204
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic syndrome and hepatocellular carcinoma risk
- (2012) F Turati et al. BRITISH JOURNAL OF CANCER
- Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women
- (2012) Juhua Luo et al. CANCER CAUSES & CONTROL
- Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort
- (2012) Sabrina Schlesinger et al. INTERNATIONAL JOURNAL OF CANCER
- Oral Insulin Secretagogues, Insulin, and Cancer Risk in Type 2 Diabetes Mellitus
- (2012) Chia-Hsuin Chang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis
- (2011) Hong-Bo Ren et al. CANCER CAUSES & CONTROL
- Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis
- (2011) Ping Wang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Cancer occurrence in Danish diabetic patients: duration and insulin effects
- (2011) B. Carstensen et al. DIABETOLOGIA
- Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-analysis of cohort studies
- (2011) Chenggang Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting insulin-like growth factor axis in hepatocellular carcinoma
- (2011) Jennifer Wu et al. Journal of Hematology & Oncology
- Hepatocellular Carcinoma Risk Factors and Disease Burden in a European Cohort: A Nested Case-Control Study
- (2011) D. Trichopoulos et al. JNCI-Journal of the National Cancer Institute
- Validez del diagnóstico referido de diabetes, hipertensión e hiperlipemia en población adulta española. Resultados del estudio DINO
- (2011) José M. Huerta et al. REVISTA ESPANOLA DE CARDIOLOGIA
- Presence of Gallstones or Kidney Stones and Risk of Type 2 Diabetes
- (2010) C. Weikert et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Diabetes in relation to biliary tract cancer and stones: a population-based study in Shanghai, China
- (2010) F M Shebl et al. BRITISH JOURNAL OF CANCER
- Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma
- (2010) Manal M. Hassan et al. CANCER
- Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: From a Clinical to a Molecular Association
- (2010) S. Petta et al. CURRENT PHARMACEUTICAL DESIGN
- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- Epidemiology of Non-Alcoholic Fatty Liver Disease
- (2010) Stefano Bellentani et al. DIGESTIVE DISEASES
- Risk of cancer in a large cohort of U.S. veterans with diabetes
- (2010) Elizabeth A. Atchison et al. INTERNATIONAL JOURNAL OF CANCER
- Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma
- (2010) Valter Donadon WORLD JOURNAL OF GASTROENTEROLOGY
- Diabetes mellitus as a risk factor for gastrointestinal canceramong American veterans
- (2009) M Mazen Jamal et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma
- (2008) J. Polesel et al. ANNALS OF ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started